| Distal anterior compartment myopathy: a dysferlin mutation causing a new muscular dystrophy phenotype I Illa, C Serrano‐Munuera, E Gallardo, A Lasa, R Rojas‐García, J Palmer, ... Annals of Neurology: Official Journal of the American Neurological …, 2001 | 333 | 2001 |
| Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutations TR Rebbeck, TM Friebel, E Friedman, U Hamann, D Huo, A Kwong, ... Human mutation 39 (5), 593-620, 2018 | 289 | 2018 |
| Common Breast Cancer Susceptibility Alleles and the Risk of Breast Cancer for BRCA1 and BRCA2 Mutation Carriers: Implications for Risk Prediction AC Antoniou, J Beesley, L McGuffog, OM Sinilnikova, S Healey, ... Cancer research 70 (23), 9742-9754, 2010 | 255 | 2010 |
| Characterization of monoclonal antibodies to calpain 3 and protein expression in muscle from patients with limb-girdle muscular dystrophy type 2A LVB Anderson, K Davison, JA Moss, I Richard, M Fardeau, FMS Tomé, ... The American journal of pathology 153 (4), 1169-1179, 1998 | 185 | 1998 |
| Common variants in LSP1, 2q35 and 8q24 and breast cancer risk for BRCA1 and BRCA2 mutation carriers AC Antoniou, OM Sinilnikova, L McGuffog, S Healey, H Nevanlinna, ... Human molecular genetics 18 (22), 4442-4456, 2009 | 146 | 2009 |
| The wide spectrum of POT1 gene variants correlates with multiple cancer types O Calvete, P Garcia-Pavia, F Domínguez, G Bougeard, K Kunze, ... European Journal of Human Genetics 25 (11), 1278-1281, 2017 | 89 | 2017 |
| Parity and the risk of breast and ovarian cancer in BRCA1 and BRCA2 mutation carriers RL Milne, A Osorio, T Ramón y Cajal, M Baiget, A Lasa, E Diaz-Rubio, ... Breast cancer research and treatment 119, 221-232, 2010 | 83 | 2010 |
| Parity and the risk of breast and ovarian cancer in BRCA1 and BRCA2 mutation carriers RL Milne, A Osorio, T Ramón y Cajal, M Baiget, A Lasa, E Diaz-Rubio, ... Breast cancer research and treatment 119, 221-232, 2010 | 83 | 2010 |
| Identification of a novel founder mutation in the DYSF gene causing clinical variability in the Spanish population JJ Vilchez, P Gallano, E Gallardo, A Lasa, R Rojas-García, A Freixas, ... Archives of Neurology 62 (8), 1256-1259, 2005 | 74 | 2005 |
| Detection of a large rearrangement in PALB2 in Spanish breast cancer families with male breast cancer A Blanco, M de la Hoya, J Balmana, T Ramón y Cajal, A Teulé, ... Breast cancer research and treatment 132, 307-315, 2012 | 69 | 2012 |
| Analysis of PALB2 Gene in BRCA1/BRCA2 Negative Spanish Hereditary Breast/Ovarian Cancer Families with Pancreatic Cancer Cases A Blanco, M de la Hoya, A Osorio, O Diez, MD Miramar, M Infante, ... PLoS One 8 (7), e67538, 2013 | 58 | 2013 |
| Id4 is deregulated by at (6; 14)(p22; q32) chromosomal translocation in a B-cell lineage acute lymphoblastic leukemia M Bellido, A Aventín, A Lasa, C Estivill, MJ Carnicer, C Pons, ... haematologica 88 (9), 994-1001, 2003 | 56 | 2003 |
| Evaluation of Rare Variants in the New Fanconi Anemia Gene ERCC4 (FANCQ) as Familial Breast/Ovarian Cancer Susceptibility Alleles A Osorio, M Bogliolo, V Fernández, A Barroso, M De la Hoya, T Caldés, ... Human mutation 34 (12), 1615-1618, 2013 | 41 | 2013 |
| About 1% of the breast and ovarian Spanish families testing negative for BRCA1 and BRCA2 are carriers of RAD51D pathogenic variants S Gutiérrez‐Enríquez, S Bonache, G Ruíz de Garibay, A Osorio, ... International journal of cancer 134 (9), 2088-2097, 2014 | 40 | 2014 |
| Diversidad artefactual vs. Especialización funcional: análisis del IV Componente de Túnel I (Tierra del Fuego, Argentina) ME Mansur, A Lasa Magallania (Punta Arenas) 33 (2), 69-91, 2005 | 37 | 2005 |
| High expression of CEACAM6 and CEACAM8 mRNA in acute lymphoblastic leukemias A Lasa, E Serrano, M Carricondo, MJ Carnicer, S Brunet, I Badell, J Sierra, ... Annals of hematology 87, 205-211, 2008 | 36 | 2008 |
| FLT3 mutations are associated with other molecular lesions in AML MJ Carnicer, JF Nomdedéu, A Lasa, C Estivill, S Brunet, A Aventı́n, ... Leukemia research 28 (1), 19-23, 2004 | 33 | 2004 |
| Comparative analysis of ZAP‐70 expression and Ig VH mutational status in B‐cell chronic lymphocytic leukemia L Munoz, A Lasa, MT Carricondo, C Hernandez, J Ubeda, JF Nomdedéu Cytometry Part B: Clinical Cytometry: The Journal of the International …, 2007 | 31 | 2007 |
| A celecoxib derivative inhibits focal adhesion signaling and induces caspase‐8‐dependent apoptosis in human acute myeloid leukemia cells I Casanova, R Bosch, A Lasa, M Parreño, MV Céspedes, S Brunet, ... International journal of cancer 123 (1), 217-226, 2008 | 30 | 2008 |
| Acute myeloid leukemia subgroups identified by pathway-restricted gene expression signatures E Serrano, A Lasa, G Perea, MJ Carnicer, S Brunet, A Aventín, J Sierra, ... Acta haematologica 116 (2), 77-89, 2006 | 29 | 2006 |
Josep NomdedeuHospital de la Santa Creu i Sant PauVerified email at santpau.cat
